Stryve Foods And 2 Other Stocks Under $1 Insiders Are Aggressively Buying
The Dow Jones closed higher by around 146 points on Thursday. Investors, meanwhile, focused on some notable insider trades.
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
$7.3 Million Bet On This Penny Stock? Check Out These 4 Penny Stocks Insiders Are Buying
The Dow Jones dropped more than 600 points on Monday. Investors, meanwhile, focused on some notable insider trades.
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
This Financial Services Stock Surged Around 116%; Here Are 86 Biggest Movers From Yesterday
Gainers
Magic Empire Global Limited (NASDAQ: MEGL) shares jumped 115.7% to close at $17.73 on volatility following the company's IPO earlier this month.
Air-Dried Beef Company To Restructure After “Record High Revenues,” Will Raise $20M In New Financing As Shares Dive 16%
Stryve Foods Inc (NASDAQ:SNAX) reported second-quarter FY22 sales growth of 49% year-on-year to $10.95 million, missing the consensus of $13.45 million.…
Recap: Stryve Foods Q2 Earnings
Stryve Foods (NASDAQ:SNAX) reported its Q2 earnings results on Monday, August 15, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Earnings Scheduled For August 15, 2022
Companies Reporting Before The Bell
• Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter.
Why Energy Stocks Traded Higher; Here Are 61 Biggest Movers From Yesterday
Gainers
GeoVax Labs, Inc. (NASDAQ: GOVX) jumped 150.4% to close at $1.59 on Monday after declining 8% on Friday.
Why Is Infrastructure and Energy Alternatives Higher By Around 29%? 37 Stocks Moving In Monday’s Mid-Day Session
Gainers
Revelation Biosciences, Inc. (NASDAQ: REVB) jumped 104% to $1.3263 after the company announced that primary endpoint was met in study for its treatment of allergic rhinitis.
